The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular and clinical characteristics of patients with non-small-cell lung cancer (NSCLC) harboring KRAS G12V mutations.
 
Felix John
Travel, Accommodations, Expenses - Merck
 
Lea Ruge
No Relationships to Disclose
 
Heather Scharpenseel
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Janna Siemanowski
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jana Fassunke
No Relationships to Disclose
 
Richard Riedel
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Janssen Oncology; Novartis; Takeda
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Novartis; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Lilly
 
Rieke Nila Fischer
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Janssen
 
Anna Rasokat
No Relationships to Disclose
 
Wolfgang Schulte
No Relationships to Disclose
 
Karl-Josef Franke
No Relationships to Disclose
 
Ullrich Graeven
Stock and Other Ownership Interests - Biontech
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celltrion; Fujifilm; Ipsen; MSD Oncology; Novartis; Sanofi Aventis GmbH
Consulting or Advisory Role - Amgen; MSD Oncology
Research Funding - Ipsen (Inst); Macrogenics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; GlaxoSmithKline
 
Jutta Kappes
No Relationships to Disclose
 
Anna Kron
No Relationships to Disclose
 
Udo Siebolts
No Relationships to Disclose
 
Sabine Merkelbach-Bruse
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Reinhard Büttner
No Relationships to Disclose
 
Juergen Wolf
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen; Lilly; Loxo; Loxo/Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo/Lilly; Merck; Mirati Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Sanofi
 
Matthias Scheffler
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Siemens Healthineers; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Janssen Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Siemens Healthineers; Takeda
Research Funding - Amgen (Inst); BMS GmbH & Co. KG (Inst); Dracen (Inst); Janssen (Inst); Novartis (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Janssen; Pfizer